VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 38 of Oncotarget features a Scratch Kymograph image derived from the data found in, "Real-time scratch assay reveals mechanisms of early calcium signaling in breast cancer cells in response to wounding," by Pratt, et al.
|
|
Table of Contents
Research Papers: Gerotarget (Focus on Aging)
|
| Genetic variations in chromodomain helicase DNAbinding protein 5 geneenvironment interactions and risk of sporadic Alzheimer’s disease in Chinese population |
|
https://doi.org/10.18632/oncotarget.23791
|
| 24872-24881 |
Research Papers: Pathology
|
| Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anticancer nanomedicines |
|
https://doi.org/10.18632/oncotarget.25427
|
| 24882-24897 |
Research Papers: Immunology
|
| Longterm exposure to lowdose Haemophilus influenzae during allergic airway disease drives a steroidresistant neutrophilic inflammation and promotes airway remodeling |
|
https://doi.org/10.18632/oncotarget.24653
|
| 24898-24913 |
Research Papers
|
| PHLDA2 is a key oncogeneinduced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling |
|
https://doi.org/10.18632/oncotarget.3674
|
| 24914-24926 |
|
| HIV1 integrase strandtransfer inhibitor resistance in southern Taiwan |
|
https://doi.org/10.18632/oncotarget.24837
|
| 24927-24935 |
|
| Transcriptome analysis reveals a long noncoding RNA signature to improve biochemical recurrence prediction in prostate cancer |
|
https://doi.org/10.18632/oncotarget.25048
|
| 24936-24949 |
|
| Microglial SMAD4 regulated by microRNA146a promotes migration of microglia which support tumor progression in a glioma environment |
|
https://doi.org/10.18632/oncotarget.25116
|
| 24950-24969 |
|
| Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on nextgeneration sequencing and its prognostic significance |
|
https://doi.org/10.18632/oncotarget.23873
|
| 24970-24979 |
|
| Biological and metabolic effects of IACS010759 an OxPhos inhibitor on chronic lymphocytic leukemia cells |
|
https://doi.org/10.18632/oncotarget.25166
|
| 24980-24991 |
|
| The novel antiandrogen candidate galeterone targets deubiquitinating enzymes USP12 and USP46 to control prostate cancer growth and survival |
|
https://doi.org/10.18632/oncotarget.25167
|
| 24992-25007 |
|
| Realtime scratch assay reveals mechanisms of early calcium signaling in breast cancer cells in response to wounding |
|
https://doi.org/10.18632/oncotarget.25186
|
| 25008-25024 |
|
| Breast and ovarian cancer penetrance of BRCA1/2 mutations among Hong Kong women |
|
https://doi.org/10.18632/oncotarget.24382
|
| 25025-25033 |
|
| Spongesupported cultures of primary head and neck tumors for an optimized preclinical model |
|
https://doi.org/10.18632/oncotarget.25244
|
| 25034-25047 |
|
| The isoform A of reticulon4 NogoA in cerebrospinal fluid of primary brain tumor patients: influencing factors |
|
https://doi.org/10.18632/oncotarget.25278
|
| 25048-25056 |
|
| Oxidized analogs of Di1Hindol3ylmethyl4substituted benzenes are NR4A1dependent UPR inducers with potent and safe anticancer activity |
|
https://doi.org/10.18632/oncotarget.25285
|
| 25057-25074 |
|
| Characterization of HBV integration patterns and timing in liver cancer and HBVinfected livers |
|
https://doi.org/10.18632/oncotarget.25308
|
| 25075-25088 |
|
| Coimaging of the tumor oxygenation and metabolism using electron paramagnetic resonance imaging and 13C hyperpolarized magnetic resonance imaging before and after irradiation |
|
https://doi.org/10.18632/oncotarget.25317
|
| 25089-25100 |
|
| Counteracting survival functions of EBNA3C in EpsteinBarr virus EBVdriven lymphoproliferative diseases by combination of SAHA and bortezomib |
|
https://doi.org/10.18632/oncotarget.25341
|
| 25101-25114 |
|
| ADH1B promotes mesothelial clearance and ovarian cancer infiltration |
|
https://doi.org/10.18632/oncotarget.25344
|
| 25115-25126 |
|
| High expression of nucleoporin 133 mRNA in bone marrow CD138+ cells is a poor prognostic factor in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.25350
|
| 25127-25135 |
|
| Epigenetic reprogramming by naïve conditions establishes an irreversible state of partial X chromosome reactivation in female stem cells |
|
https://doi.org/10.18632/oncotarget.25353
|
| 25136-25147 |
|
| FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin |
|
https://doi.org/10.18632/oncotarget.25358
|
| 25148-25165 |
|
| Aberration hubs in protein interaction networks highlight actionable targets in cancer |
|
https://doi.org/10.18632/oncotarget.25382
|
| 25166-25180 |
|
| Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments |
|
https://doi.org/10.18632/oncotarget.25388
|
| 25181-25192 |
|
| High salt induces Pglycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx |
|
https://doi.org/10.18632/oncotarget.25391
|
| 25193-25205 |
|
| PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1positive alveolar rhabdomyosarcoma |
|
https://doi.org/10.18632/oncotarget.25392
|
| 25206-25215 |
|
| Peritumoral endothelial indoleamine 2 3dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile |
|
https://doi.org/10.18632/oncotarget.25393
|
| 25216-25224 |
|
| TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25396
|
| 25225-25243 |
|
| Exploring the roles of urinary HAI1 EpCAM & EGFR in bladder cancer prognosis & risk stratification |
|
https://doi.org/10.18632/oncotarget.25397
|
| 25244-25253 |
|
| Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in wholebody magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients |
|
https://doi.org/10.18632/oncotarget.25402
|
| 25254-25264 |
|
| Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to antiPD1 immunotherapy |
|
https://doi.org/10.18632/oncotarget.25404
|
| 25265-25276 |
|
| Clinical implications of pharmacokinetics of sunitinib malate and Ndesethylsunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients |
|
https://doi.org/10.18632/oncotarget.25423
|
| 25277-25284 |
|
| The miR1792 cluster/QKI2/βcatenin axis promotes osteosarcoma progression |
|
https://doi.org/10.18632/oncotarget.23935
|
| 25285-25293 |
|
| Prognostic roles of tumor associated macrophages in bladder cancer: a system review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.25334
|
| 25294-25303 |
Clinical Research Papers
|
| An analysis of whether sleep disorder will result in postpartum depression |
|
https://doi.org/10.18632/oncotarget.25219
|
| 25304-25314 |
|
| Predictors of surgical outcomes and survival in rectal cancer patients undergoing laparoscopic total mesorectal excision after neoadjuvant chemoradiation therapy: the interest of pelvimetry and restaging magnetic resonance imaging studies |
|
https://doi.org/10.18632/oncotarget.25431
|
| 25315-25331 |
Reviews
|
| The B cell receptor signaling pathway in mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.25011
|
| 25332-25341 |
|
| Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators |
|
https://doi.org/10.18632/oncotarget.25150
|
| 25342-25354 |
|
| SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand |
|
https://doi.org/10.18632/oncotarget.25256
|
| 25355-25382 |
Corrections
|
| Correction: Noninvasive in vivo molecular imaging of intraarticularly transplanted immortalized bone marrow stem cells for osteoarthritis treatment |
|
https://doi.org/10.18632/oncotarget.25501
|
| 25383-25383 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
